Navidea To Register Shares For Dual Listing On Tel-Aviv Stock Exchange

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals Inc., (NYSE MKT:NAVB), a biopharmaceutical company focused on the development and commercialization of precision diagnostics, therapeutics and radiopharmaceutical agents, today announced that it has filed an application for registration of shares of its common stock for dual listing on the Tel-Aviv Stock Exchange (TASE). Dual listing on the TASE is allowed in the U.S. and Israel without any additional regulatory requirements for companies whose shares are listed on certain accredited stock exchanges outside of Israel, including the NYSE MKT.

Help employers find you! Check out all the jobs and post your resume.